Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2011-06-28
2011-06-28
Aeder, Sean E (Department: 1642)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reexamination Certificate
active
07968090
ABSTRACT:
A novel gene 191P4D12(b) and its encoded protein, and variants thereof, are described wherein 191P4D12(b) exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 191P4D12(b) provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 191P4D12(b) gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 191P4D12(b) can be used in active or passive immunization.
REFERENCES:
patent: 7189507 (2007-03-01), Mack et al.
patent: 2001/0051344 (2001-12-01), Shalon et al.
patent: 2002/0090672 (2002-07-01), Rosen et al.
patent: 2002/0137160 (2002-09-01), Byatt et al.
patent: 2003/0077606 (2003-04-01), Rosen et al.
patent: 2003/0099974 (2003-05-01), Lillie et al.
patent: 2003/0148408 (2003-08-01), Frantz et al.
patent: 2003/0165831 (2003-09-01), Lee et al.
patent: 2003/0170621 (2003-09-01), McCarthy et al.
patent: 2004/0083497 (2004-04-01), Raitano et al.
patent: 2004/0259086 (2004-12-01), Schlegel et al.
patent: 1313297 (2001-09-01), None
patent: 1 074 617 (2001-02-01), None
patent: WO-99/52942 (1999-10-01), None
patent: WO-01/02568 (2001-01-01), None
patent: WO-01/18016 (2001-03-01), None
patent: WO-01/22920 (2001-04-01), None
patent: WO-01/51628 (2001-07-01), None
patent: WO-01/54474 (2001-08-01), None
patent: WO-01/55315 (2001-08-01), None
patent: WO-01/57188 (2001-08-01), None
patent: WO-01/60860 (2001-08-01), None
patent: WO-01/70979 (2001-09-01), None
patent: WO-01/90304 (2001-11-01), None
patent: WO-01/94629 (2001-12-01), None
patent: WO-02/10449 (2002-02-01), None
patent: WO-02/28902 (2002-04-01), None
patent: WO-02/059377 (2002-08-01), None
patent: WO-02/060317 (2002-08-01), None
patent: WO-02/086084 (2002-10-01), None
patent: WO-02/086443 (2002-10-01), None
patent: WO-02/099040 (2002-12-01), None
patent: WO-02/102235 (2002-12-01), None
patent: WO-03/003906 (2003-01-01), None
patent: WO-03/008444 (2003-01-01), None
patent: WO-03/024392 (2003-03-01), None
patent: WO-03/042661 (2003-05-01), None
patent: WO-2004/005458 (2004-01-01), None
patent: WO-2004/016799 (2004-02-01), None
patent: WO-2004/065545 (2004-08-01), None
Alberts et al., Molecular Biology of the Cell, 3rdEd. (1994) p. 465.
Examiner's report issued by the Australian Patent Office for AU 2003228717, mailed Aug. 31, 2007, 2 pages.
Fabre et al., The Journal of Biological Chemistry (2002) 277(30):27006-27013.
Fabre-Lafay et al., The Journal of Biological Chemistry (2005) 280(20):19543-19550.
Fu et al., EMBO Journal (1996) 15:4392-4401.
Greenbaum et al., Genome Biology (2003) 4(9):117.1-117.8.
Hacker, Gut (1997) 40:623-627.
Kroese et al., Genetics in Medicine (2004) 6:475-480.
Lucentini, The Scientist (2004) 18:20.
Mallampalli et al., Biochem. J. (1996) 38:333-341.
Pennisi, Science (1998) 281(5384):1787-1789.
Reymond et al., J. Biol. Chem. (2001) 276(46):43205-43215.
Supplementary Partial European Search Report for EP03726484.3, mailed Jun. 23, 2008, 8 pages.
Challita-Eid Pia M.
Faris Mary
Ge Wangmao
Jakobovits Aya
Raitano Arthur B.
Aeder Sean E
Agensys, Inc.
Morrison & Foerster / LLP
LandOfFree
Nucleic acids and corresponding proteins entitled... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acids and corresponding proteins entitled..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acids and corresponding proteins entitled... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2638147